{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:31:39Z","timestamp":1764401499678},"reference-count":19,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.vaccine.2008.12.062","type":"journal-article","created":{"date-parts":[[2009,2,5]],"date-time":"2009-02-05T04:56:16Z","timestamp":1233809776000},"page":"2188-2193","source":"Crossref","is-referenced-by-count":44,"title":["Comparison of a single, high-dose vaccination regimen to the standard regimen for the investigational Japanese encephalitis vaccine, IC51: A randomized, observer-blind, controlled Phase 3 study"],"prefix":"10.1016","volume":"27","author":[{"given":"Elisabeth","family":"Schuller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph S.","family":"Klade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"W\u00f6lfl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astrid","family":"Kaltenb\u00f6ck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shailesh","family":"Dewasthaly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erich","family":"Tauber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2008.12.062_bib1","first-page":"63","article-title":"Japanese encephalitis","author":"Burke","year":"1988"},{"key":"10.1016\/j.vaccine.2008.12.062_bib2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/oxfordjournals.epirev.a036087","article-title":"The epidemiology of Japanese encephalitis: prospects for prevention","volume":"14","author":"Vaughn","year":"1992","journal-title":"Epidem Rev"},{"key":"10.1016\/j.vaccine.2008.12.062_bib3","first-page":"299","article-title":"Epidemiology and control of Japanese encephalitis","volume":"45","author":"Igarashi","year":"1992","journal-title":"Wld Hlth Stats Quart"},{"key":"10.1016\/j.vaccine.2008.12.062_bib4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1086\/341247","article-title":"Japanese encephalitis vaccine for travellers: exploring the limits of risk","volume":"15","author":"Shlim","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2008.12.062_bib5","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1086\/590116","article-title":"Randomized, double-blind, placebo-controlled phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese encephalitis vaccine","volume":"198","author":"Tauber","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.12.062_bib6","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/S0140-6736(07)61780-2","article-title":"Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial","volume":"370","author":"Tauber","year":"2007","journal-title":"Lancet"},{"issue":"34","key":"10.1016\/j.vaccine.2008.12.062_bib7","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1016\/j.vaccine.2008.05.081","article-title":"Long-term Immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis vaccine IC51. Six and 12 month results of a multicenter follow-up phase 3 study","volume":"26","author":"Schuller","year":"2008","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2008.12.062_bib8","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1086\/378356","article-title":"Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen","volume":"188","author":"Monath","year":"2003","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2008.12.062_bib9","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4269\/ajtmh.1988.39.214","article-title":"Safety of a live-attenuated Japanese encephalitis virus vaccine (SA14-14-2) for children","volume":"39","author":"Xin","year":"1988","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"10.1016\/j.vaccine.2008.12.062_bib10","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1086\/517323","article-title":"Short-term safety of live attenuated Japanese encephalitis vaccine (SA14-14-2): results of a randomized trial with 26,239 subjects","volume":"176","author":"Liu","year":"1997","journal-title":"J Infect Dis"},{"issue":"13","key":"10.1016\/j.vaccine.2008.12.062_bib11","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.vaccine.2008.01.021","article-title":"A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: immunogenicity and anamnestic responses","volume":"26","author":"Sohn","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.12.062_bib12","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1016\/j.vaccine.2006.12.046","article-title":"A Phase 2 study of a purified, inactivated virus vaccine to prevent Japanese encephalitis","volume":"25","author":"Lyons","year":"2007","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2008.12.062_bib13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jcv.2008.05.001","article-title":"Japanese encephalitis in a Finnish traveler on a two-week holiday in Thailand","volume":"43","author":"Lehtinen","year":"2008","journal-title":"J Clin Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.12.062_bib14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/00365549609049074","article-title":"Fatal Japanese encephalitis in a Danish tourist visiting Bali for 12 days","volume":"28","author":"Buhl","year":"1996","journal-title":"Scand J Infect Dis"},{"issue":"8962","key":"10.1016\/j.vaccine.2008.12.062_bib15","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0140-6736(95)92990-8","article-title":"Japanese encephalitis after a 10-day holiday in Bali","volume":"345","author":"Wittesj\u00f6","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2008.12.062_bib16","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4161\/hv.3.2.3747","article-title":"Tick-born encephalitis (TBE) vaccination in children: advantage of the rapid immunization schedule (i.e., Days 0, 7, 21)","volume":"3","author":"Sch\u00f6ndorf","year":"2007","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2008.12.062_bib17","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.vaccine.2006.10.028","article-title":"Tick-borne encephalitis (TBE) vaccination: applying the most suitable vaccination schedule","volume":"25","author":"Sch\u00f6ndorf","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.12.062_bib18","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1586\/14760584.4.5.747","article-title":"Tick-borne encephalitis vaccines: past and present","volume":"4","author":"Zent","year":"2005","journal-title":"Expert Rev Vaccin"},{"key":"10.1016\/j.vaccine.2008.12.062_bib19","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1016\/j.vaccine.2003.08.005","article-title":"Kinetics of the immune response after primary and booster immunization against tick-borne encephalitis (TBE) in adults using the rapid immunization schedule","volume":"21","author":"Zent","year":"2003","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09001352?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09001352?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T16:48:39Z","timestamp":1558111719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09001352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":19,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0264410X09001352"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.12.062","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}